GraniteShares Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $710K | Buy |
|
|||||
|
2025
Q3 | $747K | Sell |
|
|||||
|
2025
Q2 | $619K | Sell |
|
|||||
|
2025
Q1 | $570K | Sell |
|
|||||
|
2024
Q4 | $533K | Sell |
|
|||||
|
2024
Q3 | $748K | Sell |
|
|||||
|
2024
Q2 | $940K | Buy |
|
|||||
|
2024
Q1 | $475K | Buy |
|
|||||
|
2023
Q4 | $534K | Sell |
|
|||||
|
2023
Q3 | $512K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $100K | Buy |
|